Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ARES MANAGEMENT CORP (ARES)

  • Business News
  • June 18, 2026, 10:30 UTC
  • 1
  • 1 comments

Ares Appoints Brent Canada as Head of Infrastructure Debt

Market reaction Comment Full text

MAYFAIR GOLD CORP. (MINE)

  • Business News
  • June 18, 2026, 10:30 UTC
  • 1
  • 1 comments

MAYFAIR GOLD REPORTS FINAL POSITIVE RESULTS AND ANALYSIS FROM GRADE CONTROL DRILLING PROGRAM

Market reaction Comment Full text

WESTPORT FUEL SYSTEMS INC. (WPRT)

  • Business News
  • June 18, 2026, 10:30 UTC
  • 1
  • 1 comments

Cespira, the Joint Venture between Westport and Volvo Group, Signs Agreement with Volvo Group to Complete Hydrogen-Fueled Engine Development

Market reaction Comment Full text

INNSUITES HOSPITALITY TRUST (IHT)

  • Business News
  • June 18, 2026, 10:27 UTC
  • 1
  • 1 comments

IHT EXPLORING REVERSE MERGER

Market reaction Comment Full text

VISHAY PRECISION GROUP, INC. (VPG)

  • Business News
  • June 18, 2026, 10:03 UTC
  • 1
  • 1 comments

DTS Introduces SLICE6 AIR-TC Thermocouple DAQ for Advanced Flight Testing

Market reaction Comment Full text

Natera Inc (NTRA)

  • Business News
  • June 18, 2026, 10:00 UTC
  • 1
  • 1 comments

Natera - Natera to Showcase Organ Health Leadership with 21 Presentations at the American Transplant Congress

Market reaction Comment Full text

Organon & Co. (OGN)

  • Business News
  • June 18, 2026, 10:00 UTC
  • 1
  • 1 comments

Organon & Co. - Organon and Samsung Bioepis Expand Agreement to Commercialize PYZCHIVA® (ustekinumab), a Biosimilar Referencing STELARA® (ustekinumab) in Canada

Market reaction Comment Full text

NIQ GLOBAL INTELLIGENCE PLC ORDINARY SHARES (NIQ)

  • Business News
  • June 18, 2026, 10:00 UTC
  • 1
  • 1 comments

NIQ and Ogury Collaborate to Enhance Media Planning and Audience Strategy with GeoPurchase Insights

Market reaction Comment Full text

ORGANON & CO. (OGN)

  • Business News
  • June 18, 2026, 10:00 UTC
  • 1
  • 1 comments

Organon et Samsung Bioepis élargissent leur entente pour la commercialisation de PYZCHIVA® (ustékinumab), un biosimilaire de référence à STELARA® (ustékinumab) au Canada

Market reaction Comment Full text

ORGANON & CO. (OGN)

  • Business News
  • June 18, 2026, 10:00 UTC
  • 1
  • 1 comments

Organon and Samsung Bioepis Expand Agreement to Commercialize PYZCHIVA® (ustekinumab), a Biosimilar Referencing STELARA® (ustekinumab) in Canada

Market reaction Comment Full text
  • Previous
  • 838
  • 839
  • 840
  • 841
  • 842
  • Next

Search

News categories

  • Technical Exchange News(13578)
  • Event(6229)
  • SEC News(353890)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(194152)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin